|
US4570630A
(en)
*
|
1983-08-03 |
1986-02-18 |
Miles Laboratories, Inc. |
Medicament inhalation device
|
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
GB9216038D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Bespak Plc |
Dispensing apparatus for powdered medicaments
|
|
HU216405B
(hu)
*
|
1993-03-03 |
1999-06-28 |
Tenax Corp. |
Hordozóelem por alakú gyógyszerek adagolására szolgáló inhalálókészülékhez
|
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
|
US5505194A
(en)
*
|
1994-03-23 |
1996-04-09 |
Abbott Laboratories |
Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
FR2731911B1
(fr)
*
|
1995-03-20 |
1997-08-14 |
Paul Seyvos |
Dispositif qui permet d'inhaler, par la bouche, l' odeur de produits contenus dans un reservoir a des fins therapeutiques
|
|
US7131441B1
(en)
|
1995-12-07 |
2006-11-07 |
Skyepharma Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
|
ATE193455T1
(de)
|
1995-12-07 |
2000-06-15 |
Jago Pharma Ag |
Inhalator zur mehrfachen dosisweisen abgabe eines pharmakologischen trockenpulvers
|
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
|
CA2212430A1
(en)
*
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Inhalation device
|
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
|
DE29908593U1
(de)
|
1999-05-14 |
1999-07-22 |
Jago Research AG, Hergiswil |
Mundstück für einen Inhalator zur Abgabe eines Medikaments
|
|
EP1941868A3
(en)
|
2000-02-28 |
2011-06-29 |
PharmaKodex Limited |
Improvements in or relating to the delivery of oral drugs
|
|
US6595210B2
(en)
*
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
|
GB2380410B
(en)
*
|
2001-10-05 |
2003-11-19 |
Alchemy Healthcare Ltd |
Apparatus for the nasal or oral delivery of a medicament
|
|
CA2477604A1
(en)
|
2002-03-13 |
2003-09-25 |
Signum Biosciences, Inc. |
Modulation of protein methylation and phosphoprotein phosphate
|
|
ITMO20020297A1
(it)
*
|
2002-10-16 |
2004-04-17 |
Roberto Oliva |
Inalatore per preparati monodose in capsule.
|
|
US20060045849A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Farhan Taghizadeh |
Method of customizing the fragrance of nasal medications
|
|
PL370285A1
(pl)
*
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy
|
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
EP1843734A4
(en)
|
2005-02-03 |
2008-09-10 |
Signum Biosciences Inc |
COMPOSITIONS AND METHOD FOR INTENSIFYING COGNITIVE FUNCTIONS
|
|
US9345745B2
(en)
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
|
WO2007052154A2
(en)
*
|
2005-04-29 |
2007-05-10 |
University Of Medicine And Dentistry Of New Jersey |
Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
|
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
|
CA2620123C
(en)
*
|
2005-08-24 |
2011-11-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for treating and monitoring inflammation and redox imbalance in cystic fibrosis
|
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
GB0604444D0
(en)
|
2006-03-06 |
2006-04-12 |
Optinose As |
Nasal devices
|
|
CA2898230C
(en)
*
|
2007-01-10 |
2018-04-24 |
Purdue Research Foundation |
Polypeptide inhibitors of hsp27 kinase and uses therefor
|
|
US9034815B2
(en)
*
|
2007-01-10 |
2015-05-19 |
Moerae Matrix, Inc |
Polypeptide for treating or preventing adhesions
|
|
WO2009021137A2
(en)
|
2007-08-07 |
2009-02-12 |
Purdue Research Foundation |
Kinase inhibitors and uses thereof
|
|
CN101980738A
(zh)
|
2008-02-07 |
2011-02-23 |
华盛顿大学 |
圆周气雾设备
|
|
CA2725143A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Neurotez, Inc. |
Methods for treating progressive cognitive disorders related to neurofibrillary tangles
|
|
EP2570147B1
(en)
*
|
2008-06-13 |
2017-10-18 |
MannKind Corporation |
A dry powder inhaler and system for drug delivery
|
|
KR20120024529A
(ko)
*
|
2008-11-04 |
2012-03-14 |
니콜라오스 테자프시디스 |
신경섬유 매듭 및 아밀로이드 베타의 축적으로부터 기인하는 진행성 인지 기능 장애의 치료용 렙틴 조성물 및 치료 방법
|
|
BRPI0922448A2
(pt)
*
|
2008-12-10 |
2021-02-17 |
Purdue Research Foundation |
inibidor com base em peptídeo penetrante celular de quinases
|
|
AU2010275476B2
(en)
|
2009-07-24 |
2015-07-23 |
Amazentis Sa |
Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
|
|
US9890195B2
(en)
*
|
2009-07-27 |
2018-02-13 |
Purdue Research Foundation |
MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
|
|
CN103917265B
(zh)
|
2011-03-03 |
2017-02-15 |
英倍尔药业股份有限公司 |
鼻药递送装置
|
|
JP6031510B2
(ja)
|
2011-04-12 |
2016-11-24 |
モイライ マトリックス インコーポレイテッド |
異常な線維芽細胞増殖及び細胞外マトリックスの沈着を特徴とする疾患、症状又はプロセスを予防又は治療する組成物及び方法
|
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
WO2012148998A1
(en)
|
2011-04-25 |
2012-11-01 |
Cornell University |
Use of uridine and deoxyuridine to treat folate-responsive pathologies
|
|
JP6645735B2
(ja)
|
2011-05-09 |
2020-02-14 |
インペル ニューロファーマ インコーポレイテッド |
鼻薬送達用ノズル
|
|
EP2589381B1
(en)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions for improving or preserving lung function in a patient with a pulmonary disorder
|
|
US9452218B2
(en)
|
2012-03-09 |
2016-09-27 |
Purdue Research Foundation |
Compositions and methods for delivery of kinase inhibiting peptides
|
|
JP2015530387A
(ja)
|
2012-09-04 |
2015-10-15 |
エライゾン ファーマシューティカルズ， エルエルシー |
脂質複合体化シスプラチンによる肺癌の再発防止
|
|
EP2991713B1
(en)
|
2013-04-28 |
2019-06-19 |
Impel Neuropharma Inc. |
Medical unit dose container
|
|
WO2015006639A1
(en)
|
2013-07-12 |
2015-01-15 |
SILVA, John, H. |
Mouthpiece for inhalers
|
|
ES2811090T3
(es)
|
2013-09-10 |
2021-03-10 |
Univ Texas |
Terapéuticos dirigidos a proteínas truncadas de poliposis adenomatosa coli (apc)
|
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
|
USD748242S1
(en)
|
2014-07-11 |
2016-01-26 |
H. Stuart Campbell |
Inhaler mouthpiece
|
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
|
JP2018501201A
(ja)
|
2014-11-17 |
2018-01-18 |
モイライ マトリックス インコーポレイテッド |
異常な線維芽細胞増殖および細胞外マトリックス沈着を特徴とする疾患、状態、またはプロセスを予防または処置するための組成物および方法
|
|
ES2796973T3
(es)
|
2014-12-10 |
2020-11-30 |
Hyperstem Sa |
Métodos y composiciones para reducir el crecimiento, la migración y la invasividad de células madre de cáncer cerebral y mejorar la supervivencia de pacientes con tumores cerebrales
|
|
RU2017128077A
(ru)
|
2015-01-08 |
2019-02-08 |
Мори Матрикс, Инк. |
Составы, содержащие пептиды, ингибирующие мк2
|
|
KR20170125090A
(ko)
|
2015-03-12 |
2017-11-13 |
모레 매트릭스 인코포레이티드 |
비-세포 폐암을 치료하기 위한 mk2 저해제 펩타이드-함유 조성물의 용도
|
|
CA2987071A1
(en)
|
2015-06-10 |
2016-12-15 |
Hackensack University Medical Center |
Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
|
|
CN107949279A
(zh)
|
2015-07-06 |
2018-04-20 |
得克萨斯系统大学评议会 |
可用作用于治疗人类癌症的抗癌剂的苯甲酰胺或苯扎明化合物
|
|
WO2017011215A1
(en)
|
2015-07-15 |
2017-01-19 |
The Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (ebp) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
|
WO2017044897A1
(en)
|
2015-09-10 |
2017-03-16 |
Impel Neuropharma Inc. |
In-line nasal delivery device
|
|
US10328216B2
(en)
|
2016-01-20 |
2019-06-25 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispensible spray dried powders suitable for inhalation
|
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
|
US11571532B2
(en)
|
2017-11-21 |
2023-02-07 |
Impel Pharmaceuticals Inc. |
Intranasal device with dip tube
|
|
CA3081680A1
(en)
|
2017-11-21 |
2019-05-31 |
Impel Neuropharma, Inc. |
Intranasal device with inlet interface
|
|
CA3087698A1
(en)
|
2018-01-05 |
2019-07-11 |
Impel Neuropharma, Inc. |
Intranasal delivery of olanzapine by precision olfactory device
|
|
KR20200118032A
(ko)
|
2018-01-05 |
2020-10-14 |
임펠 뉴로파마 인코포레이티드 |
정밀 후각기관 장치에 의한 디하이드로에르고타민의 비강내 전달
|
|
WO2020018959A1
(en)
|
2018-07-19 |
2020-01-23 |
Impel Neuropharma, Inc. |
Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's disease
|
|
CN113473967B
(zh)
|
2019-01-03 |
2022-09-09 |
英倍尔制药公司 |
经鼻药物递送装置
|
|
EP3969085A4
(en)
|
2019-05-17 |
2023-06-21 |
Impel Pharmaceuticals Inc. |
DISPOSABLE NASAL DELIVERY DEVICE
|